Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice

Victoria L. Buettner, Kathleen A. Hill, Hiroshi Nishino, Daniel J Schaid, Craig S. Frisk, Steve S. Sommer

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

p53 (-/-), lacI (+/-) double transgenic (p53/Big Blue®) mice provide an opportunity to examine the relationship in vivo between somatic mutation and tumorigenesis. Previously, the frequency and spectra of lacI mutations were found to be similar in normal tissues of 6 week old p53 (-/-) lacI (+/-) and p53 (+/+) lacI (+/-) mice. Herein, p53 (-/-), lacI (+/-) mice were used to examine the frequency and spectrum of spontaneous mutation in thymic lymphomas. Four mice with thymic lymphomas were sacrificed at 2.5, 3, 4 and 4.5 months of age. Normal thymus harvested from two p53 (+/+) lacI (+/-) mice and two p53 (-/-) lacI (+/-) mice served as controls. The mutation frequency in tumor 108 (6.8 x 10-5) was elevated 2.3-fold relative to the p53 (-/-) control (P < 0.0001; χ2 test). The mutation spectra were also different (P = 0.0009; Fisher exact test); in particular, A:T → G:C transitions were prominently overrepresented in tumor 108. In addition, there were two examples of unusual deletions with inversions. In tumors 44 and 115, but not 110, there were trends toward increased mutation frequencies and altered spectra, but, within the constraints of present sample sizes, the results are not statistically significant. In conclusion, these findings suggest that altered frequencies and spectra exist in a subset of thymic lymphomas, perhaps due to somatic mutation in one or more DNA repair genes.

Original languageEnglish (US)
Pages (from-to)2407-2413
Number of pages7
JournalOncogene
Volume13
Issue number11
StatePublished - 1996

Fingerprint

Mutation Rate
Transgenic Mice
Lymphoma
Mutation
Neoplasms
DNA Repair
Sample Size
Thymus Gland
Carcinogenesis
Genes

Keywords

  • Big Blue
  • Deletions with insertions
  • Inversions
  • Mutator phenotype
  • Point mutations
  • Transitions

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice. / Buettner, Victoria L.; Hill, Kathleen A.; Nishino, Hiroshi; Schaid, Daniel J; Frisk, Craig S.; Sommer, Steve S.

In: Oncogene, Vol. 13, No. 11, 1996, p. 2407-2413.

Research output: Contribution to journalArticle

Buettner, Victoria L. ; Hill, Kathleen A. ; Nishino, Hiroshi ; Schaid, Daniel J ; Frisk, Craig S. ; Sommer, Steve S. / Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice. In: Oncogene. 1996 ; Vol. 13, No. 11. pp. 2407-2413.
@article{8595cca0e819412f8586165362319cd7,
title = "Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice",
abstract = "p53 (-/-), lacI (+/-) double transgenic (p53/Big Blue{\circledR}) mice provide an opportunity to examine the relationship in vivo between somatic mutation and tumorigenesis. Previously, the frequency and spectra of lacI mutations were found to be similar in normal tissues of 6 week old p53 (-/-) lacI (+/-) and p53 (+/+) lacI (+/-) mice. Herein, p53 (-/-), lacI (+/-) mice were used to examine the frequency and spectrum of spontaneous mutation in thymic lymphomas. Four mice with thymic lymphomas were sacrificed at 2.5, 3, 4 and 4.5 months of age. Normal thymus harvested from two p53 (+/+) lacI (+/-) mice and two p53 (-/-) lacI (+/-) mice served as controls. The mutation frequency in tumor 108 (6.8 x 10-5) was elevated 2.3-fold relative to the p53 (-/-) control (P < 0.0001; χ2 test). The mutation spectra were also different (P = 0.0009; Fisher exact test); in particular, A:T → G:C transitions were prominently overrepresented in tumor 108. In addition, there were two examples of unusual deletions with inversions. In tumors 44 and 115, but not 110, there were trends toward increased mutation frequencies and altered spectra, but, within the constraints of present sample sizes, the results are not statistically significant. In conclusion, these findings suggest that altered frequencies and spectra exist in a subset of thymic lymphomas, perhaps due to somatic mutation in one or more DNA repair genes.",
keywords = "Big Blue, Deletions with insertions, Inversions, Mutator phenotype, Point mutations, Transitions",
author = "Buettner, {Victoria L.} and Hill, {Kathleen A.} and Hiroshi Nishino and Schaid, {Daniel J} and Frisk, {Craig S.} and Sommer, {Steve S.}",
year = "1996",
language = "English (US)",
volume = "13",
pages = "2407--2413",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice

AU - Buettner, Victoria L.

AU - Hill, Kathleen A.

AU - Nishino, Hiroshi

AU - Schaid, Daniel J

AU - Frisk, Craig S.

AU - Sommer, Steve S.

PY - 1996

Y1 - 1996

N2 - p53 (-/-), lacI (+/-) double transgenic (p53/Big Blue®) mice provide an opportunity to examine the relationship in vivo between somatic mutation and tumorigenesis. Previously, the frequency and spectra of lacI mutations were found to be similar in normal tissues of 6 week old p53 (-/-) lacI (+/-) and p53 (+/+) lacI (+/-) mice. Herein, p53 (-/-), lacI (+/-) mice were used to examine the frequency and spectrum of spontaneous mutation in thymic lymphomas. Four mice with thymic lymphomas were sacrificed at 2.5, 3, 4 and 4.5 months of age. Normal thymus harvested from two p53 (+/+) lacI (+/-) mice and two p53 (-/-) lacI (+/-) mice served as controls. The mutation frequency in tumor 108 (6.8 x 10-5) was elevated 2.3-fold relative to the p53 (-/-) control (P < 0.0001; χ2 test). The mutation spectra were also different (P = 0.0009; Fisher exact test); in particular, A:T → G:C transitions were prominently overrepresented in tumor 108. In addition, there were two examples of unusual deletions with inversions. In tumors 44 and 115, but not 110, there were trends toward increased mutation frequencies and altered spectra, but, within the constraints of present sample sizes, the results are not statistically significant. In conclusion, these findings suggest that altered frequencies and spectra exist in a subset of thymic lymphomas, perhaps due to somatic mutation in one or more DNA repair genes.

AB - p53 (-/-), lacI (+/-) double transgenic (p53/Big Blue®) mice provide an opportunity to examine the relationship in vivo between somatic mutation and tumorigenesis. Previously, the frequency and spectra of lacI mutations were found to be similar in normal tissues of 6 week old p53 (-/-) lacI (+/-) and p53 (+/+) lacI (+/-) mice. Herein, p53 (-/-), lacI (+/-) mice were used to examine the frequency and spectrum of spontaneous mutation in thymic lymphomas. Four mice with thymic lymphomas were sacrificed at 2.5, 3, 4 and 4.5 months of age. Normal thymus harvested from two p53 (+/+) lacI (+/-) mice and two p53 (-/-) lacI (+/-) mice served as controls. The mutation frequency in tumor 108 (6.8 x 10-5) was elevated 2.3-fold relative to the p53 (-/-) control (P < 0.0001; χ2 test). The mutation spectra were also different (P = 0.0009; Fisher exact test); in particular, A:T → G:C transitions were prominently overrepresented in tumor 108. In addition, there were two examples of unusual deletions with inversions. In tumors 44 and 115, but not 110, there were trends toward increased mutation frequencies and altered spectra, but, within the constraints of present sample sizes, the results are not statistically significant. In conclusion, these findings suggest that altered frequencies and spectra exist in a subset of thymic lymphomas, perhaps due to somatic mutation in one or more DNA repair genes.

KW - Big Blue

KW - Deletions with insertions

KW - Inversions

KW - Mutator phenotype

KW - Point mutations

KW - Transitions

UR - http://www.scopus.com/inward/record.url?scp=0030458031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030458031&partnerID=8YFLogxK

M3 - Article

C2 - 8957082

AN - SCOPUS:0030458031

VL - 13

SP - 2407

EP - 2413

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 11

ER -